Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 118 articles:
HTML format
Text format



Single Articles


    May 2017
  1. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    PubMed     Text format     Abstract available


  2. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.
    PubMed     Text format    


  3. TAN HK, Leow WQ, Chang PE
    Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(16)35073.
    PubMed     Text format    


  4. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.
    PubMed     Text format    


  5. ROCCARO GA, Goldberg DS
    Early Detection of Hepatocellular Carcinoma after Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?
    Gastroenterology. 2017 May 3. pii: S0016-5085(17)35551.
    PubMed     Text format    


    April 2017
  6. KALYAN A, Kulik L
    Multi-disciplinary Care in Hepatocellular Carcinoma: Where Do We Go from Here?
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35538.
    PubMed     Text format    


  7. PAN LH, Zhao C, Ma YL
    Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?
    Gastroenterology. 2017 Apr 3. pii: S0016-5085(17)30221.
    PubMed     Text format    


  8. DURAN R, Deltenre P, Denys A
    RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Apr 1. pii: S0016-5085(17)30224.
    PubMed     Text format    


    March 2017
  9. YOUNG S, Golzarian J
    Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30225.
    PubMed     Text format    


  10. GARIN E, Pallard X, Edeline J
    Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30222.
    PubMed     Text format    


  11. ZHANG W, He H, Zang M, Wu Q, et al
    Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30333.
    PubMed     Text format     Abstract available


  12. HOWELL J, Thompson AJ
    Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30334.
    PubMed     Text format    


  13. NASR P, Forsgren MF, Ignatova S, Dahlstrom N, et al
    Using a 3% Proton Density Fat Fraction as a Cut-off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results from Histopathology Analysis.
    Gastroenterology. 2017 Mar 9. pii: S0016-5085(17)30267.
    PubMed     Text format     Abstract available


  14. CHEN B, Wei W, Ma L, Yang B, et al
    Computational Discovery of Niclosamide Ethanolamine, A Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells in Vitro and in Mice by Inhibiting CDC37 Signaling.
    Gastroenterology. 2017 Mar 8. pii: S0016-5085(17)30264.
    PubMed     Text format     Abstract available


  15. SERPER M, Taddei TH, Mehta R, D'Addeo K, et al
    Association of Provider Specialty and Multi-disciplinary Care with Hepatocellular Carcinoma Treatment and Mortality.
    Gastroenterology. 2017 Mar 7. pii: S0016-5085(17)30265.
    PubMed     Text format     Abstract available


  16. MANCUSO A
    Classification of Portal Vein Thrombosis in Cirrhosis.
    Gastroenterology. 2017 Mar 3. pii: S0016-5085(17)30135.
    PubMed     Text format    


  17. NAULT JC
    Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9 Accelerator.
    Gastroenterology. 2017 Mar 1. pii: S0016-5085(17)30218.
    PubMed     Text format    


    February 2017
  18. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  19. NAKAGAWA H, Mizukoshi E, Kobayashi E, Tamai T, et al
    Association Between High-avidity T-cell Receptors, Induced by Alpha Fetoprotein-derived Peptides, and Anti-tumor Effects in Patients with Hepatocellular Carcinoma.
    Gastroenterology. 2017 Feb 7. pii: S0016-5085(17)30132.
    PubMed     Text format     Abstract available


  20. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


  21. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


    January 2017
  22. HUANG Z, Zhang F, Luo Z
    Intrahepatic Biliary Duct Dilatation With an Unusual Choledochoscope Image.
    Gastroenterology. 2017 Jan 31. pii: S0016-5085(16)35177.
    PubMed     Text format    


  23. ALONSO C, Fernandez-Ramos D, Varela-Rey M, Martinez-Arranz I, et al
    Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
    Gastroenterology. 2017 Jan 26. pii: S0016-5085(17)30072.
    PubMed     Text format     Abstract available


  24. MASSAFRA V, Milona A, Vos HR, Ramos RJ, et al
    Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Gastroenterology. 2017 Jan 24. pii: S0016-5085(17)30054.
    PubMed     Text format     Abstract available


  25. SILVA-JUNIOR G, Turon F, Baiges A, Cerda E, et al
    Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Porto-systemic Shunts in Patients With Portal Hypertension.
    Gastroenterology. 2017 Jan 24. pii: S0016-5085(17)30051.
    PubMed     Text format     Abstract available


  26. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


  27. LIN XM, Hu L, Gu J, Wang RY, et al
    Choline Kinase Alpha Mediates Interactions Between the Epidermal Growth Factor Receptor and mTORC2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Gastroenterology. 2017 Jan 5. pii: S0016-5085(17)30001.
    PubMed     Text format     Abstract available


    December 2016
  28. NAULT JC, Couchy G, Balabaud C, Morcrette G, et al
    Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Gastroenterology. 2016 Dec 7. pii: S0016-5085(16)35440.
    PubMed     Text format     Abstract available


  29. RICH N, Singal AG
    Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Potential New Challenge for Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2016;151:1246-1248.
    PubMed     Text format    


    November 2016
  30. WHITE DL, Thrift AP, Kanwal F, Davila J, et al
    Incidence of Hepatocellular Carcinoma in all 50 United States, From 2000 Through 2012.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35389.
    PubMed     Text format     Abstract available


  31. SINGAL AG, Tiro JA, Marrero JA, McCallister K, et al
    Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma.
    Gastroenterology. 2016 Nov 5. pii: S0016-5085(16)35321.
    PubMed     Text format     Abstract available


    October 2016
  32. SOYSA DR, Crispe IN
    Sub-capsular Hepatic Dendritic Cells: Hiding in Plain Sight.
    Gastroenterology. 2016 Oct 27. pii: S0016-5085(16)35277.
    PubMed     Text format    


  33. MEHTA N, Yao FY
    Trans-arterial radioembolization for hepatocellular carcinoma: who, when... and Y(90)?
    Gastroenterology. 2016 Oct 27. pii: S0016-5085(16)35278.
    PubMed     Text format    


  34. PARK HM, Russo KA, Karateev G, Park M, et al
    A System for In Vivo Imaging of Hepatic Free Fatty Acid Uptake.
    Gastroenterology. 2016 Oct 11. pii: S0016-5085(16)35185.
    PubMed     Text format     Abstract available


  35. WEERSINK RA, Drenth JP, Borgsteede SD
    Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)35074.
    PubMed     Text format    


  36. LO GH
    Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35075.
    PubMed     Text format    


  37. SOOKOIAN S, Pirola CJ
    The Exact Mechanism by Which Hepatic Transmembrane 6 Superfamily Member 2 Modulates Triglyceride Metabolism Is Still Uncertain.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35129.
    PubMed     Text format    


    September 2016
  38. ZHANG F, Sodroski C, Cha H, Li Q, et al
    Infection of Hepatocytes with HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Upregulating SMAD6 and SMAD7.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35128.
    PubMed     Text format     Abstract available


  39. PIKARSKY E, Heikenwalder M
    Focal and Local: About Ectopic Lymphoid Structures, Intrahepatic Myeloid Aggregates for T-Cell Expansion, and Other Immune Cell Aggregates in the Liver.
    Gastroenterology. 2016 Sep 28. pii: S0016-5085(16)35124.
    PubMed     Text format    


  40. BUREAU C, Thabut D, Oberti F, Dharancy S, et al
    Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Gastroenterology. 2016 Sep 20. pii: S0016-5085(16)35110.
    PubMed     Text format     Abstract available


  41. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


  42. TSAI CF, Chen MH, Wang YP, Chu CJ, et al
    Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in Population Study.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35032.
    PubMed     Text format     Abstract available


  43. GAO Q, Wang ZC, Duan M, Lin YH, et al
    Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35033.
    PubMed     Text format     Abstract available


  44. MARTINEZ-QUETGLAS I, Pinyol R, Dauch D, Torrecilla S, et al
    IGF2 is Upregulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and is an Actionable Oncogene Product in Experimental Models.
    Gastroenterology. 2016 Sep 7. pii: S0016-5085(16)35026.
    PubMed     Text format     Abstract available


  45. GUO S, Xu Y, Zhang Z
    Repeated Hepatolithiasis and Unknown Mass in Cholangiography.
    Gastroenterology. 2016 Sep 1. pii: S0016-5085(16)34656.
    PubMed     Text format    


    August 2016
  46. KALMAN RS, Goldberg DS
    Obeticholic Acid Reduces Bacterial Translocation and Inhibits Intestinal Inflammation in Cirrhotic Rats.
    Gastroenterology. 2016 Aug 28. pii: S0016-5085(16)34977.
    PubMed     Text format    


  47. SARIN SK, Philips CA, Kamath PS, Choudhary A, et al
    Towards a Comprehensive New Classification of Portal Vein Thrombosis in Patients with Cirrhosis: A Commentary.
    Gastroenterology. 2016 Aug 26. pii: S0016-5085(16)34975.
    PubMed     Text format    


  48. SALEM R, Gordon AC, Mouli S, Hickey R, et al
    Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2016 Aug 26. pii: S0016-5085(16)34971.
    PubMed     Text format     Abstract available


  49. GRUNWALD B, Harant V, Schaten S, Fruhschutz M, et al
    Pancreatic Pre-malignant Lesions Secrete TIMP1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Pre-Metastatic Niche in the Liver.
    Gastroenterology. 2016 Aug 6. pii: S0016-5085(16)34890.
    PubMed     Text format     Abstract available


    July 2016
  50. SHERMAN M
    Hepatitis B vaccination: Putting hepatologists out of business?
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34819.
    PubMed     Text format    


  51. GANE E, Poordad F, Wang S, Asatryan A, et al
    High Efficacy of ABT-493 and ABT-530 in Patients with HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34816.
    PubMed     Text format     Abstract available


  52. MASON WS, Gill US, Litwin S, Zhou Y, et al
    HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
    Gastroenterology. 2016 Jul 21. pii: S0016-5085(16)34808.
    PubMed     Text format     Abstract available


  53. CABILLIC F, Corlu A
    Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jul 18. pii: S0016-5085(16)34788.
    PubMed     Text format     Abstract available


  54. SHIN JY, Azoulay L, Filion KB
    Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?
    Gastroenterology. 2016 Jul 1. pii: S0016-5085(16)34434.
    PubMed     Text format    


    June 2016
  55. JAESCHKE H
    Mechanisms of Acetaminophen Hepatotoxicity: Do We Need JNK for Cell Death?
    Gastroenterology. 2016 Jun 30. pii: S0016-5085(16)34616.
    PubMed     Text format    


  56. TEUFEL A, Dufour JF
    Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jun 29. pii: S0016-5085(16)34706.
    PubMed     Text format    


  57. RAHMAN K, Desai C, Iyer SS, Thorn NE, et al
    Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.
    Gastroenterology. 2016 Jun 21. pii: S0016-5085(16)34679.
    PubMed     Text format     Abstract available


    May 2016
  58. KLINGE MJ, Borhani AA, Malik SM
    Hepatitis C and Numerous Disappearing Hepatic Nodules: No-dule C It, No-dule Don't.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)30099.
    PubMed     Text format    


  59. KODAMA T, Bard-Chapeau EA, Newberg JY, Kodama M, et al
    Two-step Forward Genetic Screen in Mice Identifies Ral GTPase-activating Proteins as Suppressors of Hepatocellular Carcinoma.
    Gastroenterology. 2016 May 10. pii: S0016-5085(16)34392.
    PubMed     Text format     Abstract available


  60. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    PubMed     Text format     Abstract available


  61. NEWSOME PN
    Entering the GOLDEN Age for Therapies in NASH.
    Gastroenterology. 2016;150:1073-6.
    PubMed     Text format    


    April 2016
  62. PALMER RH
    Biliary Cirrhosis Treated With Ursodeoxycholic Acid.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00363.
    PubMed     Text format    


  63. SUGA T, Arai H, Takayama H
    A Rare Cause of Esophageal Varices.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00212.
    PubMed     Text format    


  64. GINES P
    Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Telipressin and Beyond.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)34324.
    PubMed     Text format    


  65. SOREIDE K, Watson MM, Hagland HR
    Deciphering the Molecular Code to Colorectal Liver Metastasis Biology Through Microsatellite Alterations and Allelic Loss: The Good, the Bad, and the Ugly.
    Gastroenterology. 2016;150:811-4.
    PubMed     Text format    


  66. BIRKBAK NJ, Andersen JB
    Heterogeneity Among Liver Cancer--A Hurdle to Optimizing Therapy.
    Gastroenterology. 2016;150:818-21.
    PubMed     Text format    


  67. CALDERONE V, Gallego J, Fernandez-Miranda G, Garcia-Pras E, et al
    Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
    Gastroenterology. 2016;150:982-97.
    PubMed     Text format     Abstract available


    March 2016
  68. DI MARCO V, Calvaruso V, Ferraro D, Bavetta MG, et al
    Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With Stage of Portal Hypertension.
    Gastroenterology. 2016 Mar 31. pii: S0016-5085(16)30049.
    PubMed     Text format     Abstract available


  69. CHIN JL, Chan G, Ryan JD
    Noninvasive Assessment of Liver Fibrosis and Cirrhosis With Ultrasound-based Elastography in Alcohol-related Liver Disease.
    Gastroenterology. 2016 Mar 25. pii: S0016-5085(16)00301.
    PubMed     Text format    


  70. NEPHEW LD, Goldberg DS
    Impact of Anticoagulation on Upper Gastrointestinal Bleeding in Cirrhosis.
    Gastroenterology. 2016 Mar 24. pii: S0016-5085(16)00377.
    PubMed     Text format    


  71. ROCKEY DC
    A new treatment for portal hypertension?
    Gastroenterology. 2016 Mar 23. pii: S0016-5085(16)00368.
    PubMed     Text format    


  72. LASSAILLY G, Caiazzo R, Pattou F, Mathurin P, et al
    Perspectives on Treatment for Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Mar 10. pii: S0016-5085(16)00323.
    PubMed     Text format     Abstract available


  73. FERNANDES D, Vilaca S, Rolanda C
    Epigastric Pain in a Patient With Nodular Regenerative Hyperplasia.
    Gastroenterology. 2016;150:572-3.
    PubMed     Text format    


  74. TAOULI B, Serfaty L
    Magnetic Resonance Imaging/Elastography Is Superior to Transient Elastography for Detection of Liver Fibrosis and Fat in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:553-6.
    PubMed     Text format    


  75. IMAJO K, Kessoku T, Honda Y, Tomeno W, et al
    Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Gastroenterology. 2016;150:626-637.
    PubMed     Text format     Abstract available


  76. REINKE H, Asher G
    Circadian Clock Control of Liver Metabolic Functions.
    Gastroenterology. 2016;150:574-80.
    PubMed     Text format     Abstract available


  77. UTHAYA KUMAR DB, Chen CL, Liu JC, Feldman DE, et al
    TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
    Gastroenterology. 2016;150:707-19.
    PubMed     Text format     Abstract available


    February 2016
  78. SCHATTENBERG JM, Lee MS
    Extracellular Vesicles as Messengers between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 27. pii: S0016-5085(16)00255.
    PubMed     Text format    


  79. DAS S, Mahakkanukrauh P, Ho CC
    The Burden of Gastrointestinal, Liver, and Pancreatic Diseases: The Global Scenario.
    Gastroenterology. 2016 Feb 27. pii: S0016-5085(16)00136.
    PubMed     Text format    


  80. MACHADO MV, Diehl AM
    Pathogenesis of Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 26. pii: S0016-5085(16)00257.
    PubMed     Text format     Abstract available


  81. YOUNOSSI Z, Park H, Henry L, Adeyemi A, et al
    Extra-Hepatic Manifestations of Hepatitis C-a Meta-Analysis of Prevalence, Quality of Life, and Economic Burden.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00230.
    PubMed     Text format     Abstract available


  82. SANYAL AJ, Miller V
    Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00235.
    PubMed     Text format    


  83. ZHOU SL, Zhou ZJ, Hu ZQ, Huang XW, et al
    Tumor-Associated Neutrophils Recruit Macrophages and T-regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00231.
    PubMed     Text format     Abstract available


  84. GLASS L, Sharma P
    Evidence-Based Therapeutic Options for Hepatorenal Syndrome.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00241.
    PubMed     Text format    


  85. MATSUSHITA H, Yang YM, Pandol SJ, Seki E, et al
    Exosomal MIF: A Potential New Biomarker and Therapeutic Target for Pancreatic Cancer.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00242.
    PubMed     Text format    


  86. BOYER TD, Sanyal AJ, Wong F, Frederick RT, et al
    Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1.
    Gastroenterology. 2016 Feb 16. pii: S0016-5085(16)00217.
    PubMed     Text format     Abstract available


  87. RATZIU V, Harrison S, Francque S, Bedossa P, et al
    Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
    Gastroenterology. 2016 Feb 10. pii: S0016-5085(16)00140.
    PubMed     Text format     Abstract available


  88. WANG L, Yin J, Wang X, Shao M, et al
    C-type Lectin-like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of PI3K Subunits.
    Gastroenterology. 2016 Feb 5. pii: S0016-5085(16)00133.
    PubMed     Text format     Abstract available


  89. BERRY K, Ioannou GN
    Reply.
    Gastroenterology. 2016;150:535-7.
    PubMed     Text format    


  90. VITALE A, Volk ML, Senzolo M, Frigo AC, et al
    Estimation of Liver Transplant Related Survival Benefit: the Devil Is in The Details.
    Gastroenterology. 2016;150:534-5.
    PubMed     Text format    


  91. GOLDBERG DS, Charlton M
    Usefulness of Liver Transplantation in the Elderly: The Converging Impact of Risk and Benefit.
    Gastroenterology. 2016;150:306-9.
    PubMed     Text format    


  92. SU F, Yu L, Berry K, Liou IW, et al
    Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.
    Gastroenterology. 2016;150:441-53.
    PubMed     Text format     Abstract available


    January 2016
  93. KRISS M, Wachs M, Attwell A
    An Unusual Cause of Right Upper Quadrant Pain in a Patient With Prior Liver Transplantation for Primary Sclerosing Cholangitis.
    Gastroenterology. 2016 Jan 28. pii: S0016-5085(15)01070.
    PubMed     Text format    


  94. GOOSSENS N, Hoshida Y
    Is hepatocellular cancer the same disease in alcoholic and non-alcoholic fatty liver diseases?
    Gastroenterology. 2016 Jan 16. pii: S0016-5085(16)00045.
    PubMed     Text format    


  95. ABRALDES JG, Villanueva C, Aracil C, Turnes J, et al
    Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
    Gastroenterology. 2016 Jan 13. pii: S0016-5085(16)00043.
    PubMed     Text format     Abstract available


  96. FAN Y, Lu H, Guo Y, Zhu T, et al
    Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.
    Gastroenterology. 2016 Jan 13. pii: S0016-5085(16)00044.
    PubMed     Text format     Abstract available


  97. BRUIX J, Reig M, Sherman M
    Evidence-based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jan 12. pii: S0016-5085(16)00007.
    PubMed     Text format     Abstract available


  98. HIRSOVA P, Ibrahim SH, Krishnan A, Verma VK, et al
    Lipid-induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01865.
    PubMed     Text format     Abstract available


  99. XUE R, Li R, Guo H, Guo L, et al
    Variable Extent of Intra-tumor Heterogeneity Revealed by Genomic Sequencing of Multiple Lesions in Patients with Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jan 2. pii: S0016-5085(15)01861.
    PubMed     Text format     Abstract available


  100. KOI M, Garcia M, Choi C, Kim HR, et al
    Microsatellite Alterations with Allelic Loss at 9p24.2 Signify Less-aggressive Colorectal Cancer Metastasis.
    Gastroenterology. 2016 Jan 2. pii: S0016-5085(15)01860.
    PubMed     Text format     Abstract available


  101. LASSAILLY G, Caiazzo R, Mathurin P, Pattou F, et al
    Reply.
    Gastroenterology. 2016;150:284-5.
    PubMed     Text format    


  102. LIANGPUNSAKUL S, Crabb DW
    Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
    Gastroenterology. 2016;150:29-31.
    PubMed     Text format    


  103. BYRNE CD, Targher G
    Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:7-10.
    PubMed     Text format    


  104. SANYAL AJ, Neuschwander-Tetri BA, Tonascia J
    End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2016;150:11-3.
    PubMed     Text format    


  105. FABBRINI E, Tiemann Luecking C, Love-Gregory L, Okunade AL, et al
    Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.
    Gastroenterology. 2016;150:79-81.
    PubMed     Text format     Abstract available


    December 2015
  106. MEHTA N, Heimbach J, Hirose R, Roberts JP, et al
    Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?
    Gastroenterology. 2015 Dec 21. pii: S0016-5085(15)01748.
    PubMed     Text format    


  107. LENCIONI R, Braet F
    Novel Transarterial Biomimetic-based Nanoparticles for the Treatment of Hepatocellular Carcinoma.
    Gastroenterology. 2015 Dec 19. pii: S0016-5085(15)01817.
    PubMed     Text format    


  108. CUBERO FJ, Eugenio Zoubek M, Peng J, Hu W, et al
    Combined activities of JNK1 and JNK2 in hepatocytes protect against toxic liver injury.
    Gastroenterology. 2015 Dec 18. pii: S0016-5085(15)01814.
    PubMed     Text format     Abstract available


  109. VILAR-GOMEZ E, Friedman SL, Romero-Gomez M
    Reply: To PMID 25865049.
    Gastroenterology. 2015;149:1988-9.
    PubMed     Text format    


    November 2015
  110. MU X, Pradere JP, Affo S, Dapito DH, et al
    Epithelial Transforming Growth Factor-beta Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Gastroenterology. 2015 Nov 25. pii: S0016-5085(15)01721.
    PubMed     Text format     Abstract available


  111. GERHARD GS, Still CD, DiStefano JK
    High False-negative Rate for Nonalcoholic Steatohepatitis in Extreme Obesity.
    Gastroenterology. 2015 Nov 23. pii: S0016-5085(15)01582.
    PubMed     Text format    


  112. TAPPER EB, Leffler DA
    The Morbidity and Mortality Conference in Gastroenterology and Hepatology: An Important Cornerstone of Patient Safety and Optimal Care.
    Gastroenterology. 2015 Nov 22. pii: S0016-5085(15)01674.
    PubMed     Text format    


  113. HASSAN MM, Abdel-Wahab R, Li D, Kaseb AO, et al
    Reply: To PMID 25836985.
    Gastroenterology. 2015;149:1643-4.
    PubMed     Text format    


  114. LEE JH, Yoon JH
    Reply: To PMID 25747273.
    Gastroenterology. 2015;149:1640-1.
    PubMed     Text format    


    October 2015
  115. TEH JL, Lee KC, Tan KK
    An Unusual Cause of a Large Liver Abscess.
    Gastroenterology. 2015;149:e7-9.
    PubMed     Text format    


  116. MICHALOPOULOS GK, Khan Z
    Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease.
    Gastroenterology. 2015;149:876-82.
    PubMed     Text format     Abstract available


    August 2015
  117. PEERY AF, Crockett SD, Barritt AS, Dellon ES, et al
    Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States.
    Gastroenterology. 2015 Aug 28. pii: S0016-5085(15)01242.
    PubMed     Text format     Abstract available


  118. WANG D, Fu L, Sun H, Guo L, et al
    Prostaglandin E Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Gastroenterology. 2015 Aug 7. pii: S0016-5085(15)01097.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: